Controlled growth factor delivery for tissue engineering. - Wikidata - awgldk - TriplyDB

Controlled growth factor delivery for tissue engineering.

Controlled growth factor delivery for tissue engineering.

http://www.wikidata.org/entity/Q37794872

about

Small-molecule based musculoskeletal regenerative engineering Biomaterial delivery of morphogens to mimic the natural healing cascade in bone Therapeutic angiogenesis: controlled delivery of angiogenic factors.Biomimetic approaches with smart interfaces for bone regeneration Magnetic hydroxyapatite bone substitutes to enhance tissue regeneration: evaluation in vitro using osteoblast-like cells and in vivo in a bone defect Long-Term Controlled Protein Release from Poly(Ethylene Glycol) Hydrogels by Modulating Mesh Size and Degradation Non-invasive and Non-destructive Characterization of Tissue Engineered Constructs Using Ultrasound Imaging Technologies: A Review.Biodegradable electrospun nanofibers coated with platelet-rich plasma for cell adhesion and proliferation Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164 Amphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate.Modulation of Host Osseointegration during Bone Regeneration by Controlling Exogenous Stem Cells Differentiation Using a Material Approach PLGA/nHA hybrid nanofiber scaffold as a nanocargo carrier of insulin for accelerating bone tissue regeneration IGF-1 release kinetics from chitosan microparticles fabricated using environmentally benign conditions.Immobilization of murine anti-BMP-2 monoclonal antibody on various biomaterials for bone tissue engineering.3D Bioprinting for Tissue and Organ Fabrication.Hydrogels as a platform for stem cell delivery to the heart.Peptide-Functionalized Click Hydrogels with Independently Tunable Mechanics and Chemical Functionality for 3D Cell Culture.Evaluating the feasibility of utilizing the small molecule phenamil as a novel biofactor for bone regenerative engineering.The role of small molecules in musculoskeletal regeneration.Multilayered Inorganic Microparticles for Tunable Dual Growth Factor Delivery.Liposomes in tissue engineering and regenerative medicine Capillary Network-Like Organization of Endothelial Cells in PEGDA Scaffolds Encoded with Angiogenic Signals via Triple Helical Hybridization.Opportunities for multicomponent hybrid hydrogels in biomedical applications Injectable solid hydrogel: mechanism of shear-thinning and immediate recovery of injectable β-hairpin peptide hydrogels Application of AMOR in craniofacial rabbit bone bioengineering.Polymeric nanofibers in tissue engineering PLLA-PEG-TCH-labeled bioactive molecule nanofibers for tissue engineering.Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.Calcium ion-induced formation of β-sheet/-turn structure leading to alteration of osteogenic activity of bone morphogenetic protein-2.Chondroitin Sulfate- and Decorin-Based Self-Assembling Scaffolds for Cartilage Tissue Engineering Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor.Biomaterial-mediated strategies targeting vascularization for bone repair.Stabilization of proteins by nanoencapsulation in sugar-glass for tissue engineering and drug delivery applications.Coadministration of platelet-derived growth factor-BB and vascular endothelial growth factor with bladder acellular matrix enhances smooth muscle regeneration and vascularization for bladder augmentation in a rabbit model.Material strategies for creating artificial cell-instructive niches Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo Biomimetic delivery with micro- and nanoparticles Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.A controlled double-duration inducible gene expression system for cartilage tissue engineering Designing degradable hydrogels for orthogonal control of cell microenvironments.

P2860

Q26821892-B18AE9E3-273B-401D-BA0C-D895E4B4D483 Q26996479-ED3B6E33-F1E2-4953-807D-88C9B9FBDD4D Q27023731-F1998816-B8D7-406F-8265-1B1B4FA29EB6 Q28068084-C6B3A6C8-DE32-4889-A010-FD2D3DDF06BC Q28484148-A9ECCA76-CE64-472D-A911-5C79FA97DBE3 Q28818334-3A760088-8730-4EC6-8325-03D4AF454FBE Q30362064-91E3FDE2-4A3D-42B9-93F5-ECCC65023F8A Q30580423-1F7ABE77-36F1-4796-9E53-64397B5BE243 Q33627325-F179B84B-1715-46F6-9CED-726876D38780 Q33700332-62B251DB-661D-469B-ABDD-14583FA7736A Q33835361-2B72F7A0-B0F0-4D12-8B30-A5CCB57B3882 Q33847292-774846E3-E836-4E45-9754-62228A37F07C Q33954621-77630685-6308-4A55-A6C2-69BEB4F5FFBF Q34043034-FA0ECD7F-5E53-436B-AE57-A5583FAB8AEC Q34046716-42824816-3339-4502-9683-BC8BD1E0CD3A Q34067076-7A6446DF-BC14-4C2D-9074-544810685051 Q34121709-92C80C9A-D6DC-4486-9EA7-0A276B796364 Q34344443-79AD1EE6-014D-425B-9E84-3BBA4B221480 Q34346326-68B47BFF-41C4-4CA4-AA76-5A161E0C6D3F Q34377102-943E44B0-39C1-4EAB-B977-263A9C901D15 Q34470412-ECEFC2B6-78C2-4227-9850-46AD1F0C668C Q34756553-C64EA5E1-96CB-4A34-8B16-85D77F66C933 Q34959739-6F9D305A-1D11-4BAA-863C-9983D45B93E9 Q34964222-A094F571-974A-4ADB-9E4B-019B4BFD93D4 Q35075242-86D67BDF-2665-4CA7-BCA5-55E450E97905 Q35230879-F705EDD0-023D-48E5-90BA-C93F12179412 Q35488306-704FCA41-0622-4732-9C82-FABBE67BBF69 Q35602789-DD4272D3-4CF5-4F24-8AA1-A8B11B943B45 Q35891530-3D111412-3C3A-49DF-98FE-BD82000412B4 Q36055521-F676CE52-D4C2-4F48-8733-D29D9097926F Q36194967-8B8A12B3-14FF-4C8D-8E6F-2522A58A186A Q36326923-949F87C4-1F46-490D-8C63-7B72AA5FB64A Q36452952-5C754517-58CE-4669-98D8-3D03616F59FC Q36490832-5F6AE7B5-9ACE-48B8-8423-D240561851BF Q36501879-3E7251B3-1C1F-45A6-AC8F-395AF7816FF8 Q36528148-399AA1A4-46A2-47A1-8C2D-0727CECD182A Q36768786-B047B797-4F3C-40AA-8CA8-F223495AB0AF Q36915712-2666A9E2-85B0-4089-9166-70810637F730 Q36933832-C612E55C-4313-4EFD-8F20-C76679A42927 Q37146704-7BCFB19F-912A-4C12-94A6-09AD5DE8254C

P2860

Controlled growth factor delivery for tissue engineering.

http://www.wikidata.org/entity/Q37794872

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Controlled growth factor delivery for tissue engineering.

@en

Controlled growth factor delivery for tissue engineering.

@nl

type

label

Controlled growth factor delivery for tissue engineering.

@en

Controlled growth factor delivery for tissue engineering.

@nl

prefLabel

Controlled growth factor delivery for tissue engineering.

@en

Controlled growth factor delivery for tissue engineering.

@nl

P1433

Q37794872-2DD0A783-C641-44D9-87E6-6C9F11AC4DC6

P1476

Q37794872-2CAC8885-7F73-464E-A77C-91163C9E0E91

P2093

Q37794872-B57FC100-D1AE-4696-A47B-679909C5FF98

Q37794872-B7DF2ED1-283E-44DE-A15B-2F5A448C5AB2

P2860

Q37794872-07CAB8CD-EEB7-4F30-ACAC-B5A1B0F053DE

Q37794872-3979269F-87DA-4AA1-9290-3590E2E82B0C

Q37794872-3C316EF2-780C-4E47-8102-39D3F43660ED

Q37794872-43034DCD-698F-469A-89FD-410FE23C3355

Q37794872-5990E99F-67AC-4E37-BCA0-BB1546488B84

Q37794872-7EC9A493-AC6D-40EC-AA04-FCCF2EE0310C

Q37794872-94992978-4BB5-4E37-B7F1-529460A4D003

P304

Q37794872-2B46EBE9-46F0-4A0B-A94A-379B91B818B5

P31

Q37794872-45CB53D4-C4EB-4953-9FDA-CF36AA3F3F85

P356

Q37794872-B771405D-9D5E-48F7-BC52-A5F0C6287DC3

P407

Q37794872-7DBE6DD8-FEF3-4DBE-8AD8-7EB1F4F9A422

P433

Q37794872-B142FDD8-2C50-4D39-844B-0ECA71D4F978

P478

Q37794872-B2077F53-6DC9-4794-9AD4-AE80D7ED7C10

P577

Q37794872-F55523FD-64E9-4267-8DF3-71AA63E5C52A

P698

Q37794872-99440019-2E00-4C8C-BBAA-D037E845972C

P921

Q37794872-4CCF870A-AE64-4ACC-A2C5-6C697275A919

P356

P1433

Advanced Materials

P1476

Controlled growth factor delivery for tissue engineering.

@en

P2093

David J Mooney

http://www.w3.org/2001/XMLSchema#string

Prakriti Tayalia

http://www.w3.org/2001/XMLSchema#string

P2860

Epidermal growth factor receptor distribution during chemotactic responses.

Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena

Mechanisms of gradient sensing and chemotaxis: conserved pathways, diverse regulation.

Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta

Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts

Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells.

Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.

P304

3269-3285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ADMA.200900241

http://www.w3.org/2001/XMLSchema#string

P407

P433

32-33

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20882497

http://www.w3.org/2001/XMLSchema#string

P921

tissue engineering